Skip to main content
Clinical Trials/NCT03640247
NCT03640247CompletedPhase 1

Are Narcotic Pain Medications Necessary Following Thyroidectomy and Parathyroidectomy

MetroHealth Medical Center1 site in 1 country126 target enrollmentStarted: November 15, 2018Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 1
Status
Completed
Enrollment
126
Locations
1
Primary Endpoint
Overall mean pain as assessed by 10 point visual analogue scale from the 6 post operative day time points.

Study Overview

Brief Summary

The purpose of this study is to evaluate the use of a non-narcotic, postoperative pain management regimen on patients undergoing thyroidectomy and parathyroidectomy.

Detailed Description

The purpose of this study is to evaluate the use of a non-narcotic, postoperative pain management regimen for patients undergoing thyroidectomy and parathyroidectomy. The investigators hypothesize that participants receiving non-narcotic pain regimens will have equivalent pain control and satisfaction to those who receive narcotic pain medicines.

The primary objective will be to identify if there is a difference in average perceived postoperative pain scores between participants who do and do not receive narcotic pain medications. Secondary outcomes will include need for breakthrough pain medications, patient satisfaction scores and the need to call the surgeon office for additional pain medications.

The participant will undergo total thyroidectomy, partial thyroidectomy or parathyroidectomy per the standard of care. The study will have no influence on the surgical procedure performed.

Following the surgery, postoperative analgesia regimens will be prescribed based on study randomization.

Narcotic group regimen (63 patients):

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Masking Description

All party or parties involved have knowledge of the interventions assigned to individual participants

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age 18 years or greater
  • Undergoing total thyroidectomy, partial thyroidectomy or parathyroidectomy at MetroHealth Medical Center

Exclusion Criteria

  • Patients taking narcotics prior to surgery
  • Patients who are unable or unwilling to follow study protocol requirements

Arms & Interventions

Narcotic group regimen

Other
  • Tylenol tablet 1000 mg by mouth every 8 hours alternating with
  • Ibuprofen tablet 800 mg by mouth every 8 hours
  • Oxycodone 5 mg by mouth every 6 hours as needed for pain, #10 tablet or if needed based on patient allergies, hydrocodone 5 mg/tramadol 50 mg.

Intervention: Narcotic group regimen (Drug)

Non-narcotic group regimen

Active Comparator
  • Tylenol tablet 1000 mg by mouth every 8 hours alternating with
  • Ibuprofen tablet 800 mg by mouth every 8 hours

Intervention: Non-narcotic group regimen (Drug)

Outcomes

Primary Outcomes

Overall mean pain as assessed by 10 point visual analogue scale from the 6 post operative day time points.

Time Frame: Overall mean pain score from 6 time points (Post operative days 0,1,2,3,4,5)

10 point visual analogue scale- (0- no pain, 1-3 mild, 4-6 moderate pain, 7-10 severe pain).

Secondary Outcomes

  • Patient satisfaction with the pain medication regimen as assessed by 3-point likert scale from the 6 post operative day time points.(Mean patient satisfaction score from 6 time points (Post operative days 0,1,2,3,4,5))
  • Total dose of oral narcotics converted into oral morphine equivalents (see below) that were taken by participants post-operatively(Mean oral morphine equivalents from 6 time points (Post operative days 0,1,2,3,4,5))
  • Mean number of office calls/contacts from the 6 post operative day time points.(Mean number of office calls/contacts from 6 time points (Post operative days 0,1,2,3,4,5))

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Christopher McHenry

MD, Director, Division of General Surgery

MetroHealth Medical Center

Study Sites (1)

Loading locations...

Similar Trials